Cristian L.
- Country
- Italy
- Department
- Oncologia Medica
Research Overview
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
- Phase 3 Randomized Study of Belzutifan Plus Zanzalintinib Versus Belzutifan Plus Placebo in Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
- Avelumab Maintenance Versus Best Supportive Care After Second-Line Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma (AVESEC Trial)
Data & Insights
Has run more than one trial at 127 of 291 partner sites.
Specializations
Advanced Renal Cancer Management
The investigator specializes in treating advanced renal cell carcinoma (RCC), with particular focus on post-nephrectomy care and metastatic disease management.
- Clear Cell Renal Cell Carcinoma
- Metastatic RCC Treatment
- Post-surgical Therapeutic Approaches
Their work encompasses both localized and systemic treatment strategies for renal malignancies.
Immunotherapy Applications
The investigator focuses on immunotherapeutic interventions in renal cancer treatment, particularly exploring various checkpoint inhibitor combinations.
- Checkpoint Inhibitor Therapy
- Combination Treatment Strategies
- Novel Immunotherapy Approaches
Their expertise extends to evaluating immune responses in various RCC treatment settings.
Targeted Therapy Innovation
The investigator has developed expertise in targeted therapeutic approaches for renal cancer, including novel molecular pathways and combination strategies.
- MET-driven Cancer Treatment
- Multi-targeted Therapeutic Approaches
- Innovative Drug Combinations
Their work includes evaluation of both established and emerging targeted therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.